StageZero Life Sciences Ltd (TSE:SZLS)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - SZLS

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - SZLS

  • Market CapCAD53.860m
  • SymbolTSE:SZLS
  • IndustryHealthcare
  • SectorDiagnostics & Research
  • Currency
  • ISINCA8525403017

Company Profile

StageZero Life Sciences Ltd is a Canadian company which is focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. It develops a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. The lead product of the company is ColonSentry which is a blood test to determine the patient's current risk of having colorectal cancer.GeneNews Ltd is focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications.

Latest SZLS news

Currently there for this company. Visit our news hub for other news .